ICD-10-CM code · FY2027
E09.352 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula
Header codeNot billable: use one of the 4 billable codes below
About E09.352
EvidencePulse™by 2 Minute Medicine®
Go deeper into drug-induced diabetes.
Ask about the latest evidence, the landmark trials or what guidelines recommend, with every study cited. No ads, no sponsored answers.
Coding notes for E09.352
No notes of its own; the notes below apply from the codes above it.
7th character Required: add one of these as the 7th character, with X as a placeholder to fill six characters.
| Character | Meaning |
|---|---|
| 1 | right eye |
| 2 | left eye |
| 3 | bilateral |
| 9 | unspecified eye |
Also applies, from E09.35 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy
7th character
- One of the following 7th characters is to be assigned to codes in subcategory E09.35 to designate laterality of the disease:
Also applies, from E09 Drug or chemical induced diabetes mellitus
Excludes1 Not coded here: never report these together with this code (use the code given instead).
- diabetes mellitus due to underlying condition (E08.-)
- gestational diabetes (O24.4-)
- neonatal diabetes mellitus (P70.2)
- postpancreatectomy diabetes mellitus (E13.-)
- postprocedural diabetes mellitus (E13.-)
- secondary diabetes mellitus NEC (E13.-)
- type 1 diabetes mellitus (E10.-)
- type 2 diabetes mellitus (E11.-)
Code first Report the underlying condition's code before this one.
Use additional code Add a second code for the detail named here.
Chapter 4 notes (apply to every code in it)
Note
- All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
Codes under E09.352 4
- E09.3521 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, right eyeBillable
- E09.3522 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, left eyeBillable
- E09.3523 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, bilateralBillable
- E09.3529 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, unspecified eyeBillable
Related codes in E09.35
- E09.351 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with macular edemaHeader
- E09.353 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the maculaHeader
- E09.354 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachmentHeader
- E09.355 Drug or chemical induced diabetes mellitus with stable proliferative diabetic retinopathyHeader
- E09.359 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy without macular edemaHeader
Latest research on drug-induced diabetes
- Cataract surgery is associated with increased incidence of diabetic retinopathy among patients with diabetes
- Telehealth yields modest improvements in diabetes outcomes
- Tirzepatide improves blood sugar control in metformin-refractory type 2 diabetes
- Smoking and prior acute pancreatitis attacks are risk factors for poor glycemic control in patients with post-chronic pancreatitis diabetes
- Weekly basal insulin efsitora effective for managing type 2 diabetes
2MM+
Read the research behind every diagnosis
2MM+ gives you every study summary in full, Classics downloads of the landmark trials, EvidencePulse and HypeCheck, and ad-free reading.
See 2MM+ plansICD-10-CM FY2027 code set, as published by the CDC National Center for Health Statistics (NCHS) and CMS, effective October 1, 2026 to September 30, 2027. Codes, titles and notes are shown as published. Check payer rules and the official guidelines before billing. This page is not medical advice.
Get the app